login
Current Deals

company details

PHILIPS INDIA LIMITED

  • www.philips.co.in
  • Sector: Healthcare
  • CHRYSEUM SCORE: 8.00/10.00
    ×

    PHILIPS INDIA LIMITED

    • Sector: Healthcare
    • CHRYSEUM SCORE: 8.00/10.00

    Description: Philips India Limited is a subsidiary of Royal Philips of the Netherlands, a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.

    Evaluation is basis the latest financial year disclosures filed by the company

    Valuation

    Max Score: 3.50

    P/E of Company

    21.76

    AVG P/E of Key Peer/s

    42.75

    Valuation Score

    3.50

    The Valuation Score depicts if the company is available at a discount when compared to its listed/unlisted peers. Higher the discount, more is the score given to the company.

    Growth

    Max Score: 3.50

    Sales Growth

    6.07%

    PAT Growth

    5.17%

    ROE

    20.76%

    Growth Score

    1.50

    The Growth Score accounts for the growth in Sales and PAT on a 3 year CAGR basis and the Company’s ROE as per the latest financial year results released by the company.

    Leverage

    Max Score: 1.50

    Debt / Equity

    0.00

    AVG Industry Debt / Equity

    0.00

    Leverage Score

    1.50

    Lower the Debt/Equity, higher the score.

    Management Quality

    Max Score: 1.50

    Board Structure & Composition

    1.00

    Related Party Transactions

    1.00

    Timely Disclosure

    1.00

    Management Score

    1.50

    This score represents a consolidated view of the Company’s Management Quality, which includes Board Structure, Related Party Transactions and Timely disclosures. Each parameter is scored out of 1.

₹1180.00 0.00 (0.00%)

As on 05 Dec, 2025
L 880.00 52 Week Range H 1215.00
Company Description : A subsidiary of Royal Philips of the Netherlands a leading health technology company focused on enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care.
Company Overview
  • Name of Company PHILIPS INDIA LIMITED
  • Sector Healthcare
  • ISIN INE319A01016
  • Scrip Code PHILIPS INDIA
  • CIN U31902WB1930PLC006663
  • Pan No AABCP9487A
  • Face Value 10
  • Price ₹ 1180.00
  • No. of Shares outstanding 5.75 Cr.
  • Market Cap ₹ 6,787.03 Cr
Financials
  • Revenue from operations ₹ 6,542.00 Cr.
  • EBITDA ₹ 679.80 Cr.
  • EBITDA Margin % 10.39%
  • Profit After Tax ₹ 309.30 Cr.
  • PAT Margin % 4.66%
  • EPS 53.78
  • Stock P/E 21.94
  • Book Value Per Share 313.58
  • P/B 3.76
  • Debt/Equity 0.00
Other Key Statistics
  • 52 week High/Low 1215.00/880.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years 6.07%
  • EBITDA Growth - 3 years 19.45%
  • PAT Growth - 3 years 5.17%
  • EPS Growth - 3 years 5.17%
  • ROE 17.15%
  • ROCE 19.08%
  • Cash Equivalents 247.30
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY25
Company Name Philips India Siemens Ltd
Listing Status Unlisted Listed
Revenue from Operations 6,542.00 16,065.80
Total Income 6,630.60 16,779.60
Finance Cost 57.10 25.70
Depreciation & Amortization 174.70 269.70
Total Expenses 6,182.60 14,462.50
EBITDA 679.80 2,612.50
PAT 309.30 2,606.60
No. of Shares Outstanding 5.75 35.61
EPS (in ₹) 53.78 73.19
Share Capital 57.50 71.20
Total Net Worth 1,489.60 12,326.20
Total Assets 3,915.70 21,947.10
Total Debt 0.00 0.00
Key Metrics:
CMP* 1,180.00 3,325.90
Market Cap (In Cr.) 6,787.03 118,435.30
Market Cap/Sales 1.02 7.06
EPS (Earnings Per Share) 53.78 73.19
BVPS (Book Value Per Share) 313.58 346.12
P/E 21.94 45.44
P/BV 3.76 9.61
EBITDA Margin 10.39% 16.26%
ROE 20.76% 21.15%
ROA 7.90% 11.88%
*Market Price in ₹ as on 05 Dec, 2025

Profit Loss

FY25 FY24 FY23 FY22 FY21
Revenue from operations 6,542.00 6,000.40 5,734.00 5,481.40 5,583.90
Y-o-Y Revenue Growth 9.03% 4.65% 4.61% -1.84% 7.50%
Other Income 88.60 60.90 71.90 64.80 55.50
Total Income 6,630.60 6,061.30 5,805.90 5,546.20 5,639.40
Total Expenses (Excludes Interest and Depreciation) 5,950.80 5,553.00 5,330.20 5,147.30 5,126.60
Operating Profit (After deducting Depreciation) 416.50 304.80 275.30 195.70 313.30
OPM % 6.37 5.08 4.80 3.57 5.61
EBITDA 679.80 508.30 475.70 398.90 512.80
Depreciation 174.70 142.60 128.50 138.40 144.00
EBIT 505.10 365.70 347.20 260.50 368.80
Interest 57.10 38.80 26.40 27.20 27.20
EBT before Exceptional Items 448.00 326.90 320.80 233.30 341.60
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 0.00 -130.90 21.60
Profit before tax/EBT 448.00 326.90 320.80 364.20 320.00
Tax 138.70 69.40 60.80 98.30 75.30
Net Profit 309.30 257.50 260.00 265.90 244.70
Profit (loss) of minority interest 0.00 0.00 0.00 0.00 0.00
Total profit (loss) for period 309.30 257.50 260.00 265.90 244.70
EPS in Rs 53.78 44.78 45.21 46.23 42.56
EPS Change % 20.09% -0.95% -2.21% 8.62% 70.31%
EBITDA Change % 33.74% 6.85% 19.25% -22.21% 14.57%
Profit growth 20.12% -0.96% -2.22% 8.66% 70.29%
ROCE 19.08% 15.57% 20.42% 9.42% 12.71%
ROE 17.15% 17.29% 21.06% 11.68% 10.23%
Debt / Equity Ratio 0.00 0.00 0.00 0.00 0.00
Sales growth 3Years 6.07% 2.43% 3.35%
Sales growth 5Years 4.72% 4.08%
Dividend per share 0.00 0.00 222.00 3.00

Balance Sheet

FY25 FY24 FY23 FY22 FY21
Share Capital 57.50 57.50 57.50 57.50 57.50
Reserves 1,746.10 1,432.10 1,176.80 2,220.00 2,334.50
Total shareholders' funds 1,803.60 1,489.60 1,234.30 2,277.50 2,392.00
Borrowings 0.00 0.00 0.00 0.00 0.00
Other Liabilities 290.40 327.90 313.50 257.40 785.80
Total Liabilities 2,268.90 2,426.10 2,005.80 2,067.40 2,014.40
Fixed Assets 922.90 943.10 386.00 344.10 476.50
Capital WIP 8.30 24.90 115.80 26.90 41.40
Investments 4.40 4.70 5.00 5.30 0.00
Other Assets 460.30 369.20 445.30 862.90 1,876.40
Total Assets 4,072.50 3,915.70 3,240.10 4,344.90 4,406.40
Cash Equivalents 247.30 272.80 211.80 1,315.90 931.30
Total Current liability 1,425.50 1,567.50 1,540.10 1,579.90 1,505.40
Total Assets -Total Current liabilty 2,647.00 2,348.20 1,700.00 2,765.00 2,901.00

Cash Flow

FY25 FY24 FY23 FY22 FY21
Net Cash from / (used in) Operating Activity 127.90 735.50 341.30 131.70 826.10
Net Cash from / (used in) Investing Activity -63.80 -582.90 -52.90 368.20 -234.30
Net Cash from / (used in) Financing Activity -89.60 -91.70 -1,392.50 -115.30 -99.70
Net Inc/Dec In Cash And Cash Equivalents -25.50 61.00 -1,104.10 384.60 492.20

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 5.53 96.13%
Non Promoters 0.22 3.87%

News

© 2022 Chryseum Advisors LLP. All rights reserved. LLPIN – AAD-0626

+91 98925 31672 | info@chryseum.in

For latest updates

Linkedin-in